Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-24 Purchase |
2021-05-26 4:04 pm |
PetVivo Holdings Inc. | PETV | Martin James Joseph Director |
3,000 | $7 | $21,000 | 67,384 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-09 Option Award |
2024-10-11 4:05 pm |
N/A N/A |
Cocrystal Pharma Inc. | COCP | Martin James Joseph Co-CEO and CFO |
40,000 | $0 | 40,569 (Direct) |
View |
| 2023-07-18 Option Award |
2023-07-20 4:05 pm |
N/A 2033-07-18 |
Cocrystal Pharma Inc. | COCP | Martin James Joseph Co-CEO and CFO |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-07-25 Option Award |
2022-08-03 4:03 pm |
N/A 2032-07-25 |
Cocrystal Pharma Inc. | COCP | Martin James Joseph Co- Interim CEO and CFO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-07-16 Option Award |
2021-07-20 4:06 pm |
N/A 2031-07-16 |
Cocrystal Pharma Inc. | COCP | Martin James Joseph Chief Financial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-03-12 Exercise |
2021-04-05 3:43 pm |
2019-12-31 2024-12-31 |
PetVivo Holdings Inc. | PETV | Martin James Joseph Director |
6,894 | $0 | 135,345 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 4:05 pm |
N/A 2030-06-22 |
Cocrystal Pharma Inc. | COCP | Martin James Joseph Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |